Volume 38 Issue 2, February 2020

Volume 38 Issue 2

Engineering plants for vertical farms

Compact, early-fruiting ‘triple-determinate’ tomato and groundcherry plants suitable for vertical farming are produced using genome editing.

See Kwon et al.

Image: David Harris, Freight Farms, Boston. Cover Design: Erin Dewalt.

Editorial

  • Editorial |

    The US Food and Drug Administration is sticking to its plan to carry out mandatory premarket review of all gene-edited livestock, irrespective of trait risk. It should rethink.

News

Bioentrepreneur

    Building a Business

  • Building a Business |

    A detailed look at the economic impact of university-licensed life science startups across the United States reveals vast differences in the effectiveness of different regions to create ventures and sustain them as viable entities.

    • Paul C. Godfrey
    • , Gove N. Allen
    •  & David Benson

Correspondence

Features

    Patents

  • Patents |

    An analysis of the emerging patent landscape of gene therapies under development, focusing on non-viral vectors.

    • Virginia Picanço-Castro
    • , Cristiano Gonçalves Pereira
    • , Dimas Tadeu Covas
    • , Geciane Silveira Porto
    • , Aglaia Athanassiadou
    •  & Marxa Leão Figueiredo
  • Patents |

    Recent patents related to lysosome-targeted therapeutics and methods of screening and visualization.

News & Views

  • News & Views |

    In a step toward nanopore sequencing of proteins, an aerolysin pore discriminates many of the proteinogenic amino acids.

    • Stefan Howorka
    •  & Zuzanna S. Siwy
  • News & Views |

    Engineering perishable crops for use in indoor farms promises to expand the adoption of this high-yielding, efficient means of food production.

    • Cathryn A. O’Sullivan
    • , C. Lynne McIntyre
    • , Ian B. Dry
    • , Susan M. Hani
    • , Zvi Hochman
    •  & Graham D. Bonnett

Research

Amendments & Corrections

Careers & Recruitment

    Career Feature

  • Career Feature |

    A quarterly snapshot of job expansions, reductions and availability in the biotech and pharma sectors.

    • Michael Francisco
  • People

  • People |

    Recent moves of note in and around the biotech and pharma industries.